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Anthropometric measurements as a risk for hypertensive disorders
in pregnancy: A hospital based study in South Asian population
Ferha Saeed,1 Ahmed Jawad,2 Asma Azmat,3 Iqbal Azam,4 Safdar Kagazwala5
Department of Obstetrics & Gynecology,1,5 Final Year Medical Student,2,3 Department of Community Health Sciences,4
Aga Khan University Hospital, Karachi, Pakistan.
Abstract
Objective: To determine the relationship between pregnancy induced hypertensive diseases and obesity.
Methods: A retrospective case controlled study was performed at Aga Khan University Hospital
including records from July 2000 to June 2005. All women developing hypertension with or without
proteinuria after 20 weeks of pregnancy (n=218) were included. Categories of pregnancy induced
hypertensive diseases (PIHD) were defined according to National high blood pressure working group
and ACOG committee bulletin. Controls were selected randomly with a ratio of 1:1.7 between cases
and controls. 
Results: The estimated prevalence of pre-eclampsia in our institution is 1.9%. Earlier reports suggested mostly
non-Asian women primigravida were more likely to develop gestational hypertension when compared with
multigravidae (p-value=0.004). Mean BMI of cases was significantly higher than controls (p=<0.001). The risks
of both non-protienuric hypertension (Mean BMI= 27.16±5.46) and preeclampsia (Mean BMI= 27.39±6.15)
increased consistently with increasing BMI. This rise was significantly associated with severity of pre-eclampsia
and early development of PIH, but not associated with complications like eclampsia. No significant association
of height and hypertension was found as most women of both cases and control were 150-165 cm tall.
Conclusions: High BMI in pregnant women serves as a significant risk factor for developing
hypertension in pregnancy but failed to establish this association with height is the main findings of our
study.
Keywords: Anthrometric measurement, hypertion in pregnancy (JPMA 61:58; 2011).
Introduction
Pregnancy induced hypertension affects 10% of
pregnancies, and pre-eclampsia complicates 2-8% of
pregnancies.1 Although obstetricians now distinguish
'transient hypertension' (without proteinuria) from 'pre-
eclampsia' (with proteinuria) and from 'superimposed pre-
eclampsia' (with pre-existing hypertension);2 risk factors for
these often overlap.3 Aside from an immediate threat to the
mother's life (worldwide, it results in an estimated 75000
maternal deaths annually),4 there is also a growing realization
that pre-eclampsia predicts an excess mortality of mothers in
later life, particularly from cardiovascular disease.5,6
However, no clear guidelines are available to identify women
at risk. A history of pre-eclampsia should be considered when
assessing the risk of cardiovascular disease in women.7
Pregnancy induced hypertensive diseases (PIHD) and
especially its ominous entity pre-eclampsia share a number of
risk factors (Atherosclerosis, obesity, endothelial disease and
pre existing hypertension) with cardiovascular diseases.
Women with recurrent pre-eclampsia or pre-eclampsia in early
pregnancy reportedly have an increased long term risk of
cardiovascular disease (CVD).6,8 A recent study has shown
women with pre-eclampsia who had preterm deliveries had an
eight fold risk of dying from cardiovascular disease compared
to those women who had given birth at term.6 Women with
recurrent pre-eclampsia or pre-eclampsia early in pregnancy
reportedly have an increased long-term risk of CVD.
Height and weight are two of the most easily obtained
anthropometric measurements. In combination, they have
been used to demonstrate the health risks associated with
being overweight as well as underweight and are used
extensively in screening and monitoring programmes.9
Short stature and increased BMI are known markers
for CVD.10,11 Obesity has been reported to be associated with
pre eclampsia and other hypertensive disorders of pregnancy
and later on in life with cardiovascular disease.12 Compared
with European women, South Asian women have high levels
of abdominal obesity even when they fall within normal
range of BMI13,14 and the risk associated with cardiovascular
disease occurs at lower BMI as compared with white
population.12 This is attributed to their body fat distribution
with more visceral fat and consequently more dyslipidaemia
which may account for increased prevalence of
cardiovascular diseases.
Height, since it is used to calculate the BMI, is not
commonly reported among the results for reasons that either
no association was found or not measured. However, we were
able to identify a few articles where information on
pregnancy related hypertension in relation to categories of
maternal height was presented. Only a few studies have
explored the association between height and pre-eclampsia.
Short stature is a risk factor for CVD but has rarely been
examined in relation to gestational hypertension. It might as
well be an additional risk marker for pregnancy induced
hypertensive diseases which may help to provide biological
clues to the etiology. A recent study has shown that short
height is associated with pre-eclampsia.15 Considering the
female Southeast Asian population where average height
might be slightly shorter with higher mean body mass index
than the Caucasian population,16 we performed this
retrospective study in 218 mothers who had PIHD over 5
year's period to determine its relationship with
anthropometric measurements.
Patients and Methods 
Hospital Management Information Systems (HMIS)
of the Aga Khan University Hospital kept the information of
the patients who were either admitted or who came in for a
consultation at the out-patient clinics of the hospital using
ICD-9-CM, in a computerized database system. In this study,
we included all women who developed hypertension with or
without proteinuria after 20 weeks of pregnancy as cases
(n=218) during July 2000 and June 2005. Pregnancies
complicated with chronic hypertension, a pre-pregnancy
diagnosis of hypertension or, pregnancies where diagnosis of
hypertension was made before the 20th week of gestation,
were excluded from the study. 
All categories of pregnancy induced hypertensive
diseases (PIHD) were defined according to the report of the
National high blood pressure working group and ACOG
committee bulletin.17,18 If a woman was delivered more
than once in the study period, the earliest delivery was
included in the analysis. If in any of the multiple deliveries,
a woman was found to be hypertensive, she was regarded
as a case throughout. Controls were randomly selected
from the same time period with a ratio of 1:1.7 between
cases and controls. Women in control group were selected
with the exception of those who fulfilled the predefined
criteria of Pregnancy induced Hypertension, Preeclampsia,
Eclampsia or Chronic Hypertension. All other women with
pregnancy induced complications not a result of
Hypertensive disorders were included in the study. All
cases with incomplete records were excluded from the
study. The resultant sample size for 586 subjects achieves a
power of 80 percent with an anticipated odds ratio of 2,
level of significance of 5 percent and the exposure among
controls ranged from 11.2 percent to 78.5 percent.
Data was double entered by two different data entry
operators using data entry software Epidata (version 3.0) in
order to minimize data entry errors and analyzed using SPSS
for Windows, Release 14.0 (Statistical Package for Social
Sciences Inc., Chicago, IL, USA). Student's t-test was used to
compare cases and controls for continuous variables like age
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of women at the time of booking, height of mother (in cm),
body mass index at the time of booking, gestational weeks at
the time of booking, gestational weeks at the time of delivery,
birth weight of baby and duration of surgical ICU stay (in
days).2 and Fisher's exact tests were used to compare the
association between cases and controls in categorical variables
like women age (in groups) at the time of booking, parity
(primi or multi gravida), height (in groups) of women, body
mass index (in groups) at the time of booking, patient's
mother’s history of hypertension, family history of
hypertension, delivery status, IUGR, Abruptio Placenta, CPD,
Foetal Distress and surgical ICU stay. Simple and Multiple
logistic regressions were used to evaluate the association
between pre-eclampsia and the various risk factors and
reported as crude and adjusted odds ratios 95% confidence
intervals for uni-variate and multi-variable analysis.
We examined the effect of mother's height by dividing
height into three categories (<150 cm, 150-165 cm and  165
cm). BMI at the time of antenatal booking was used for the
analysis and the subjects were divided into groups according
to maternal BMI the cut offs recommended by WHO.19
Results
Out of a total of 15,000 women who gave birth in our
hospital in the last five years 281(1.9%; 95% C.I.: 1.7%,
2.1%) women developed pregnancy induced hypertension.
Sixty-eight cases had an incomplete record and hence were
excluded from the study. Out of the remaining 218 cases, 135
had established Pre-eclampsia and 83 had pregnancy induced
hypertension only. Primigravida were more likely to develop
gestational hypertension when compared with Multigravidae
(p<0.004). Mean BMI of cases was significantly higher than
controls (p<0.001). The risk of both non protienuric
hypertension (Mean BMI= 27.16±5.46) and pre-eclampsia
(Mean BMI= 27.39±6.15) increased consistently with
increasing booking body mass index, with a higher booking
mean gestational age for cases as compared to controls
(Table-1).
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Table-1: Demographic and Physical Characteristics of mothers having PE/PIH (cases) and controls.
Characteristics Pregnancy induced hypertension Controls p-value
and Pre-eclampsia ( n = 218) (n = 371)
Mother’s Age Group at Booking (in years): 0.065
<25 67 (30.7%) 100 (27.0%)
25-29 77 (35.3%) 146 (39.4%)
30-34 44 (20.2%) 95 (25.6%)
> 35 30 (13.8%) 30 (8.1%)
Mean age (SE) 27.68 (0.382) 27.50 (0.241)
Parity: 0.004
Primi-gravida 115 (52.8%) 150 (40.4%)
Multi-gravida 103 (47.2%) 221 (59.6%)
Mean parity (SE) 1.00 (0.094) 1.05 (0.064)
Height of Mother (in cm): 0.055
<150 11 ( 5.0%) 26 ( 7.0%)
150-164.99 194 (89.0%) 304 (81.9%)
> 165 13 ( 6.0%) 41 (11.1%)
Mean height (SE) 157.25 (0.356) 157.97 (0.307)
Booking Body Mass Index (kg./m2): <0.001
<18.5 8 (3.7%) 24 (6.5%)
18.5-22.9 36 (16.5%) 122 (32.9%)
23.0-24.9 43 (19.7%) 70 (18.9%)
25.0-29.9 68 (31.2%) 99 (26.7%)
> 30.0 63 (28.9%) 56 (15.1%)
Mean BMI (SE) 27.30 (0.399) 24.64 (0.260)
Gestational Weeks at Booking: 0.024
Mean gestational weeks (SE) 16.44 (0.683) 14.66 (0.446)
Patient’s Mother’s history of Hypertension: 0.019
Yes 13 (6.0%) 8 (2.2%)
No 205 (94.0%) 363 (97.8%)
Family history of Hypertension: <0.001
Yes 126 (57.8%) 95 (25.6%)
No 92 (42.2%) 276 (74.4%)
SE means Standard Error of mean.
Subjects with higher BMI (Obese) and lower BMI
(underweight) were more likely to develop pre-eclampsia and
pregnancy induced hypertension. Increasing BMI was
significantly associated with severity of pre-eclampsia and
early development of pregnancy induced hypertension but
not associated with complications like eclampsia. It also had
no relationship with an early development of pre-eclampsia.
Similar findings for height and BMI were obtained when
pregnancy induced hypertension and pre-eclampsia
separately compared with controls. No significant association
of height and hypertension was found as most women of both
cases and control were 150-165 cm tall.
The cases (PE and PIH) however were associated with
nulliparity, a higher rate of IUGR (p<0.001), and a family
history of hypertension (p<0.001) The cases ended up having
increased surgical ICU stay (p<0.001) and as expected a
significantly higher rate of, smaller babies and a much higher
frequency of preterm deliveries compared with the women
without hypertension. The frequency of operative deliveries
and caesarian-sections (p<0.001), was much higher among
cases. No significant difference was found for maternal age,
abortion, duration of marriage foetal distress between cases
and control. In the stratified analysis based on parity status
(primigravida and multigravida) no association between
cases and controls were obtained. Pregnancy hypertension
was a significant predictor of low birth weight (Table-2).
In the univariate analysis, mother’s age group at
booking, parity, height of mother, body mass index,
gestational weeks at booking, mother’s history of
hypertension, family history of hypertension, delivery status
and surgical ICU stay were found significant (Table-2).
In multi variate analysis, the variables included in the
model were mother’s age group at booking, parity, body mass
index, family history of hypertension, delivery status and
surgical ICU stay (Table-2).
Two way ANOV A of height (em.) were found to be
insignificant for PE/PIH status (F(1,579)=3.471, p-
value=O.063), interaction between body mass index and
PE/PIH status (F(4,579)=1.504, p-value=O.200) and BMI
status (F(4,579)=1.627, p-value=O.166) (Figure-1a).
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Table-2: Crude and Adjustment estimates of the factors of
Pre-eclampsia/pregnancy induced hypertension.
Characteristics Crude Odds Adjusted Odds
Ratio (95% C.I.) Ratio (95%
C.I.)
Mother Age Group at Booking (in years):
<25 0.67 (0.37, 1.21) 0.62 (0.28, 1.33)
25-29 0.53 (0.30, 0.94) 0.46 (0.23, 0.92)
30-34 0.46 (0.25, 0.86) 0.40 (0.19, 0.83)
> 35 (Ref.) 1 1
Parity:
Primi-gravida 1.64 (1.17, 2.31) 2.09 (1.30, 3.35)
Multi-gravida (Ref.) 1 1
Height of Mother (in cm):
<150 0.66 (0.32, 1.37)
150-164.99 (Ref.) 1
> 165 0.50 (0.26, 0.95)
Pregnancy Body Mass Index (kg./m2):
<18.5 0.48 (0.28, 0.82) 0.37 (0.20, 0.69)
18.5-22.9 (Ref.) 1 1
23.0-24.9 1.12 (0.68, 1.82) 1.26 (0.72, 2.20)
25.0-29.9 1.83 (1.09, 3.09) 1.74 (0.94, 3.23)
> 30.0 0.54 (0.22, 1.32) 0.49 (0.18, 1.32)
Gestational Weeks at Booking: 1.02 (1.01, 1.04)
Mother’s history of Hypertension:
Yes 2.88 (1.17, 7.06)
No (Ref.) 1
Family history of Hypertension:
Yes 3.98 (2.79, 5.68) 3.97 (2.65, 5.96)
No (Ref.) 1 1
Delivery Status:
Vaginal (SVD) (Ref.) 1 1
Instrumental/C-section 3.35 (2.34, 4.80) 2.46 (1.64, 3.69)
Surgical ICU Stay:
Yes 19.57 (5.90, 64.97) 16.48 (4.66,
58.25)
No (Ref.) 1 1 Figure 1 (a & b): Relationship between Height (cm) and Body Mass Index (Kg./sq.
m) for PE/PIH and Normal Women.
Similarly, Two way ANOV A of BMI (Kg./sq. m) was
found to be significant for PE/PIH status (F(1,583)=16.802,
p-value<O.OOl), but were insignificant for interaction
between height groups and PE/PIH status (F(2,583)=O.885,
p-value=0.413) and height groups (F(2,583)=0.437, p-
value=O.646) (Figure-1b).
Discussion
The estimated prevalence of pre-eclampsia in our
institution is 1.9%, which is lower than that of previous
reports from mostly non-Asian women, despite being a
tertiary care referral centre, where we tend to receive higher
number of high risk cases.20 The association of hypertension
and BMI at booking was observed and showed relationship of
obesity and hypertension. Eskenazi et al. had demonstrated a
similar result.21 Obesity and hypertension are linked in
pregnancy as in the non-pregnant state.15 Obesity and
hypertension in overall population is very high in Pakistan,
which increases risk of developing hypertension in
pregnancy.22 In a systematic review of 13 cohort studies of
approximately 1 million women, O'Brien et al.23 found that
the risk of pre-eclampsia doubled for each 5-7 unit increase
in prepregnancy body mass index (BMI). Although we could
not find the pre pregnancy weight of our study population due
to its retrospective record review nature, but major fraction of
our patients (56% and 28% respectively) were booked in first
and second trimester.
Our findings show that short stature and risk of pre-
eclampsia are not related. Short stature has been reported to be
related to increased risk pre-eclampsia, and these are the
women who are an elevated risk of developing CVD. No
association was also observed for height and risk of pre-
eclampsia when studied separately for primi and
Multigravidae, which is contrary to the observation made by a
Danish study.15 In their study they have shown a positive
association of pre eclampsia with short stature in Multigravidae
where, to a large extent, it might reflect pre-existing sub-
clinical maternal disease and this might explain the stronger
association between short stature and severe pre-eclampsia
seen in multiparas, if short stature is in fact a marker of CVD.8
Such an association may be related to the progressive
vascular endothelial damage that occurs with aging.
Obstruction of the maternal spiral arteriolar Lumina by
atherosis have been frequently observed in pregnancies
complicated by pre-eclampsia. Therefore, we believe women
at an advanced age should be followed carefully for the
possible development of pre-eclampsia. A significant
association was observed between parity and pre-eclampsia,
where nulliparous women had higher incidence of pre-
eclampsia as compared to multigravida, which is consistent
with other investigations that are population-based,12,16,17
hospital-based,18,19 or other types of studies18,21,22 in which
the incidence of pre eclampsia has been found to be greater in
first births than in later ones. In clinical practice, the extent to
which pre-eclampsia would occur as mainly a disease of
primigravida would depend on the fraction of patient's seen in
their first pregnancies. In our study, we could not demonstrate
that having a previous history of abortion protected against
pre-eclampsia. A limitation of the present study is the
inability to differentiate between spontaneous and induced
abortion because of the lack of information on this variable.
Some workers suggested previously that a history of
spontaneous abortion, which usually occurs later in gestation,
provided a protection against pre eclampsia.6,13
Although high BMI was seen as a significant risk
factor for developing hypertension in pregnancy in our series
but we were not able to establish the association of height
with pre-eclampsia. Our study revealed that the prevalence of
pre-eclampsia in our institution is 1.9%, which is lower than
that of previous reports from mostly non-Asian women. As
one of the tertiary care referral centre, where we tend to
receive higher number of high risk cases, we expected an
increased prevalence. Therefore we can derive the conclusion
that frequency of pre-eclampsia in our general population
should be even lower. The reason for this disparity remains
unknown; however, we believe that a difference in the
prevalence of environmental or genetic risk factors may
partially contribute to this discrepancy and merits further
research to be conducted on the topic.
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